Balancing tissue and tumor formation in regenerative medicine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22896673.
- Also identified by DOI 10.1126/scitranslmed.3003685.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A set of general principles can guide preclinical testing strategies for evaluating the tumorigenicity of regenerative medicine products.
Medical subject headings
- Cell Transformation, Neoplastic
- Regenerative Medicine
- Tissue Engineering